[NASDAQ] Acoustic Shockwave Device to Go After a $10 Billion Market

Breakthrough Acoustic Shockwave Revealed   The NASDAQ is full of hidden gems if you know what to look for and, in this edition, we have a very unique scope for our subscribers! A med device company that has a proprietary acoustic shockwave device that is targeting a $10 billion aesthetics market. On March 21st, 2020, they will be releasing to the investing public their pivotal cellulite trial data, which was started after they completed a proof-of-concept cellulite trial that resulted in a 20-47% improvement in patient's cellulite severity score! With this news pending, here are a few highlights about the company: They've spent more than $30 million dollars over the past 5 years developing their breakthrough acoustic shockwave device that is targeting tattoo removal, cellulite reduction and keloid/hypertrophic scars Their executive and science advisory teams, as well as their board of directors, are comprised of aesthetic and medical device experts, including senior management from the makers of CoolSculpting (the leading non-surgical fat reduction technology that was acquired by Allergan for over $56 per share, for a total purchase price of $2.4B). They were recently added to the Russell 2000 and 3000 indexes They recently received FDA 510(k) clearance for their Generation 1 device Secured 8 patent families (with 101 patents issued or pending) Completed their IPO at $5 per share and has since reached a high of $29 per share Click this link to [WATCH] a video about this company and to learn about their pending news.   This is a paid message provided to our subscribers. Although we have sent you this email, we do not endorse this product or featured company nor is it responsible for it's content. We make no assurance about what is mentioned above.

---

This is a PAID ADVERTISEMENT provided to customers of StockEarnings. Although we have sent you this email, StockEarnings does not specifically endorse this product nor is it responsible for the content of this advertisement. Furthermore, we make no assurance or warranty about what is advertised above.

PLEASE NOTE: In conformity with Section 17(b) of the Securities Act of 1933, you are hereby advised that StockEarnings Inc. "StockEarnings's" is receiving a fee of over $1000.00 in cash, from an independent third party as compensation for the distribution of this advertisement. StockEarnings's has not determined if the statements and opinions of the advertiser are accurate, correct or truthful. The purpose of this advertisement, like any advertising, is to provide publicity for the advertising company, its products or services. You should not rely on the information presented; you should do independent research to form your own opinion and decision. Information contained in our disseminated emails does not constitute investment, judicial or tax advice upon which you should rely. The purchase of high-risk securities may result in the loss of your entire investment.

Advertisements received by you are not a solicitation or recommendation to buy securities of the advertised company. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the States or other jurisdictions in which the security is eligible for sale. Advertisements distributed through disseminated emails are not disclosure documents. If you are considering purchasing any securities of an advertised company, you should call your State Securities Administrator to determine if the security may be sold in your State. Many companies have information filed with State securities regulators who may be able to supply you with additional information. You also should read and review, if and to the extent available, any information concerning an advertised company available at the web sites of the U.S. Securities and Exchange Commission (the "SEC") at http://www.sec.gov and the Financial Industry Regulatory Authority (the "FINRA") at http://www.FINRA.org. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud at http://www.sec.gov/consumer as well as related information published by the NASD on how to invest carefully. You are responsible for verifying all claims and conducting your own due diligence.

You agree and acknowledge that any hyperlinks to the website of (1) an advertised company, (2) the party issuing or preparing the information for the advertised company, or (3) other information contained in our disseminated emails is provided only for your reference and convenience. We are not responsible for the accuracy or reliability of these external sites, nor are we responsible for the content, advertising, opinions, products or other materials on external sites or information sources. If you use, act upon or make decisions in reliance on information contained in any disseminated email or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on us, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink. You also acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser. You acknowledge that you will consult with your own advisers regarding any decisions as to any advertised company.

Unsubscribe

StockEarnings.com